Back to Agenda

Looking forward to this session? Share it!

It’s no secret that pharmaceutical companies are facing a number of headwinds when it comes to improving reputation. Between scrutiny on pricing, overall distrust of the industry and a consistent presence on the legislative agenda, pharmaceutical companies have little daylight when it comes to improving reputation. But it’s not all grim. Research shows that people are more likely to do business with, and work for, companies with a positive reputation. In this session, attendees will learn:

  • Why it’s critical to focus on reputation at the corporate level and how it drives real business value
  • How to identify a specific audience and create an audience-led content approach that enhances reputation
  • What digital channels best support reputation programs and how to plan for any emerging issues
  • How to measure the impact of reputation programs to demonstrate value